Compare GNK & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GNK | EMBC |
|---|---|---|
| Founded | 2004 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 732.0M | 719.7M |
| IPO Year | 2005 | N/A |
| Metric | GNK | EMBC |
|---|---|---|
| Price | $18.83 | $11.84 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $19.00 | $18.50 |
| AVG Volume (30 Days) | 457.3K | ★ 798.6K |
| Earning Date | 11-05-2025 | 02-05-2026 |
| Dividend Yield | ★ 7.77% | 5.00% |
| EPS Growth | N/A | ★ 20.90 |
| EPS | N/A | ★ 1.62 |
| Revenue | $331,332,000.00 | ★ $1,080,400,000.00 |
| Revenue This Year | N/A | $2.18 |
| Revenue Next Year | $2.64 | $0.09 |
| P/E Ratio | ★ N/A | $7.41 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.20 | $9.20 |
| 52 Week High | $19.60 | $21.23 |
| Indicator | GNK | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | 61.52 | 41.14 |
| Support Level | $18.00 | $11.64 |
| Resistance Level | $18.77 | $12.16 |
| Average True Range (ATR) | 0.28 | 0.42 |
| MACD | -0.02 | 0.10 |
| Stochastic Oscillator | 89.09 | 57.90 |
Genco Shipping & Trading Ltd is an international shipping company specializing in the transportation of iron ore, coal, grain, steel products and other drybulk cargoes. It is involved in the ocean transportation of drybulk cargoes. The company operates in one segment, with two reportable segment: Major and Minor bulk fleet. It generates revenue through time charter agreements, spot market voyage charters, pool agreements and spot market-related time charters. oyage revenues also include the sale of bunkers consumed during short-term time charters pursuant to the terms of the time charter agreement.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.